Skip to content
10-Q

Quarterly Report

CASI PHARMACEUTICALS, INC.

0001558370-22-008457

← back to feed
Filed
May 12, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 6, 2022 136.06M sh
Shares Diluted Q1 2022 · Mar 31, 2022 137.96M sh
Shares Diluted restated Q1 2022 · Mar 31, 2021 124.82M sh
Stock Repurchased Q1 2022 · Mar 31, 2022 $3M
Capex Q1 2022 · Mar 31, 2022 $2.29M
Capex Q1 2022 · Mar 31, 2021 $981K
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$4.24M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$8M
Short Term Investments Q1 2022 · Mar 31, 2022 $8.23M
Short Term Investments Q1 2022 · Dec 31, 2021 $9.87M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $29.26M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $38.7M
Stockholders Equity Q1 2022 · Mar 31, 2022 $74.99M
Stockholders Equity Q1 2022 · Dec 31, 2021 $84.5M
Stockholders Equity Q1 2022 · Mar 31, 2021 $100.03M
Stockholders Equity Q1 2022 · Dec 31, 2020 $81.54M
Current Liabilities Q1 2022 · Mar 31, 2022 $13.87M
Current Liabilities Q1 2022 · Dec 31, 2021 $13.19M
Total Liabilities Q1 2022 · Mar 31, 2022 $30.85M
Total Liabilities Q1 2022 · Dec 31, 2021 $30.34M
Current Assets Q1 2022 · Mar 31, 2022 $52.7M
Current Assets Q1 2022 · Dec 31, 2021 $61.97M
Total Assets Q1 2022 · Mar 31, 2022 $129.56M
Total Assets Q1 2022 · Dec 31, 2021 $138.3M
Eps Diluted Q1 2022 · Mar 31, 2022 −$0.06
Eps Diluted Q1 2022 · Mar 31, 2021 −$0.11
Eps Basic Q1 2022 · Mar 31, 2022 −$0.06
Eps Basic Q1 2022 · Mar 31, 2021 −$0.11
Sga Expense Q1 2022 · Mar 31, 2022 $5.33M
Sga Expense Q1 2022 · Mar 31, 2021 $5.5M
Net Income Q1 2022 · Mar 31, 2022 −$8.6M
Net Income Q1 2022 · Mar 31, 2021 −$13.88M
Operating Income Q1 2022 · Mar 31, 2022 −$7.29M
Operating Income Q1 2022 · Mar 31, 2021 −$15.6M
Gross Profit Q1 2022 · Mar 31, 2022 $5.3M
Gross Profit Q1 2022 · Mar 31, 2021 $3.38M
Cost Of Revenue Q1 2022 · Mar 31, 2022 $3.76M
Cost Of Revenue Q1 2022 · Mar 31, 2021 $2.36M
Revenue Q1 2022 · Mar 31, 2022 $9.03M
Revenue Q1 2022 · Mar 31, 2021 $5.7M
Stock Issued Q1 2022 · Mar 24, 2021 15.85M sh